FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis.
about
FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
FOLFOX plus anti-epidermal gro ...... ectal cancer: A meta-analysis.
@en
FOLFOX plus anti-epidermal growth factor receptor
@nl
type
label
FOLFOX plus anti-epidermal gro ...... ectal cancer: A meta-analysis.
@en
FOLFOX plus anti-epidermal growth factor receptor
@nl
prefLabel
FOLFOX plus anti-epidermal gro ...... ectal cancer: A meta-analysis.
@en
FOLFOX plus anti-epidermal growth factor receptor
@nl
P2093
P2860
P31
P1433
P1476
FOLFOX plus anti-epidermal gro ...... ectal cancer: A meta-analysis.
@en
P2093
Baorui Liu
Datian Chen
Guangyi Gao
Xiang Zhang
Xiaoping Qian
P2860
P356
10.1097/MD.0000000000010097
P407
P5008
P577
2018-03-01T00:00:00Z